Impact of Reconstruction Method (ASIR, FBP) Used in CT on Bone SPECT/CT Image Quality (AsirTest)

November 14, 2025 updated by: Centre Hospitalier Universitaire de Nīmes

Impact of Reconstruction Method (Adaptive Statistical Iterative Reconstruction, Filtered Back Projection) Used in Computed Tomography on Bone Single-Photon- Emission-Computed-Tomography/Computed-Tomography Image Quality

The main objective of this study is to demonstrate the non-inferiority of SPECT image quality (as measured by the signal / noise ratio) obtained by ASIR reconstruction of very-low-dose CT acquisitions versus the quality of those obtained by filtered back projection (FBP) of low-dose CT acquisitions.

The lower limit of non-inferiority is set to -1, the average SPECT signal / noise ratio TEMP expected is between 5 and 6.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The secondary objectives of this study are:

A. Demonstrate the non-inferiority of image quality (as assessed by a Likert scale) obtained by ASIR-reconstruction-SPECT versus FBP-reconstruction (the lower-limit of non-inferiority is set at -0.5); B. Verify the non-inferiority of image quality (as measured by the signal / noise ratio)of CT images obtained by ASIR-reconstruction versus FBP-reconstruction (the lower-limit of non-inferiority is set at -0.2); C. Verify the non-inferiority of image quality (as assessed by the Likert scale) of CT images obtained by ASIR-reconstruction versus FBP-reconstruction (the lower limit of non-inferiority is set at -0.5); D. Check that the irradiation dose received by the patient is lower for the acquisition of images reconstructed with ASIR than for the acquisition of images reconstructed with FBP.

E. Check the concordance of two evaluations of image quality (Likert scale) made by nuclear medicine physicians (blinded to each other).

Study Type

Interventional

Enrollment (Actual)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gard
      • Nîmes, Gard, France, 30029
        • CHU de Nimes - Hopital Universitaire Caremeau

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • A SPECT-CT exam is scheduled for the patient
  • The patient is able to withstand an extended position with the arms behind the head for 15 minutes (i.e. patient is able to undergo a SPECT-CT exam)

Exclusion Criteria:

  • The patient is participating in another study
  • The patient is in an exclusion period determined by a previous study
  • The patient is under judicial protection, or any kind of guardianship
  • The patient refuses to sign the consent
  • The patient has a contra-indication for a treatment necessary for this study (patient is not able to withstand an extended position with the arms behind the head for 15 minutes)
  • It is impossible to correctly inform the patient
  • The patient is pregnant, parturient, or breastfeeding
  • Emergency situations
  • Presence of osteosynthesis material (or any other material that would generate an artifact during SPECT-CT) in the spine
  • Patient behaviour hampers image acquisition

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patients undergoing SPECT-CT

The patients in this study are scheduled for a SPECT-CT at the Nîmes University Hospital as part of their normal care regimen.

Intervention: Device: Asir Image Acquisition

In addition to their normal image acquisition, a supplementary image acquisition lasting approximately 20 seconds (i.e. an ASIR image acquisition) will be carried out for each patient.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spect signal (kBq)
Time Frame: 2 hours after inclusion (during SPECT-CT scan)
The Spect signal is measure on a 1 cm^3 zone of vertebrae L3.
2 hours after inclusion (during SPECT-CT scan)
Spect noise (kBq)
Time Frame: 2 hours after inclusion (during SPECT-CT scan)
The spect noise is carried out on a 1 cm^3 zone of the aorta
2 hours after inclusion (during SPECT-CT scan)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CT signal (HU)
Time Frame: 2 hours after inclusion (during SPECT-CT scan)
measured on a 1 cm^3 zone of the aorta
2 hours after inclusion (during SPECT-CT scan)
CT noise (HU)
Time Frame: 2 hours after inclusion (during SPECT-CT scan)
measured on a 1 cm^3 zone of the aorta
2 hours after inclusion (during SPECT-CT scan)
Ratio of CT signal / CT noise
Time Frame: 2 hours after inclusion (during SPECT-CT scan)
2 hours after inclusion (during SPECT-CT scan)
Spect image quality Likert scale ranging from 1 to 5, Evaluation n°1
Time Frame: 2 hours after inclusion (during SPECT-CT scan)
2 hours after inclusion (during SPECT-CT scan)
CT image quality Likert scale ranging from 1 to 5, Evaluation n°2
Time Frame: 2 hours after inclusion (during SPECT-CT scan)
2 hours after inclusion (during SPECT-CT scan)
Radiation dose (mSv)
Time Frame: 2 hours after inclusion (during SPECT-CT scan)
2 hours after inclusion (during SPECT-CT scan)
Spect image quality Likert scale ranging from 1 to 5, Evaluation n°2
Time Frame: 2 hours after inclusion (during SPECT-CT scan)
2 hours after inclusion (during SPECT-CT scan)
CT image quality Likert scale ranging from 1 to 5, Evaluation n°1
Time Frame: 2 hours after inclusion (during SPECT-CT scan)
2 hours after inclusion (during SPECT-CT scan)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Louis Sibille, MD, Centre Hospitalier Universitaire de Nīmes

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2013

Primary Completion (Actual)

May 28, 2014

Study Completion (Actual)

May 28, 2014

Study Registration Dates

First Submitted

February 25, 2013

First Submitted That Met QC Criteria

February 25, 2013

First Posted (Estimated)

February 27, 2013

Study Record Updates

Last Update Posted (Estimated)

November 17, 2025

Last Update Submitted That Met QC Criteria

November 14, 2025

Last Verified

March 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • LOCAL/2012/LS-01
  • 2013-A00070-45 (Other Identifier: RCB number)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on SPECT-CT

Clinical Trials on Asir Image Acquisition

Subscribe